2025
SJR Q2
JCR Q2 · 2,2
106 matched articles
SCIE
Journal detail
APMIS
- Publisher
- Blackwell Munksgaard
- Country
- Denmark · Western Europe
- Type
- journal
- ISSN
-
0903464116000463
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,726
- Quartile Q2
- H-Index 107
- Cites/doc 2,32
- Docs (3y) 248
- Cites (3y) 661
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,2
- 5Y JIF 2,6
- JCI 0,55
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Immunology and Allergy Q3
- Medicine (miscellaneous) Q2
- Microbiology (medical) Q2
- Pathology and Forensic Medicine Q2
Areas
- Medicine
WoS categories
- Immunology | Microbiology | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,726 | 2,2 | 2,6 | 0,55 | Q3 | 107 |
| 2024 | Q1 | Q2 | 0,814 | 2,6 | 2,8 | 0,62 | Q3 | 103 |
| 2023 | Q2 | Q3 | 0,687 | 2,2 | 2,6 | 0,52 | Q3 | 103 |
| 2022 | Q2 | Q2 | 0,707 | 2,8 | 3,2 | 0,58 | Q3 | 103 |
| 2021 | Q1 | Q2 | 0,773 | 3,4 | 3,4 | 0,58 | Q3 | 103 |
| 2020 | Q1 | Q2 | 0,909 | 3,2 | 2,8 | 0,66 | Q3 | 103 |
| 2019 | Q1 | Q2 | 0,807 | 2,4 | 2 | 0,63 | Q3 | 103 |
| 2018 | — | Q2 | — | 2,2 | 2 | 0,63 | Q3 | — |
| 2017 | Q2 | Q2 | 0,868 | 2 | 2 | 0,62 | Q3 | 103 |
| 2016 | Q2 | Q3 | 0,822 | 1,8 | 1,8 | — | — | 103 |
| 2015 | Q1 | Q2 | 0,891 | 1,9 | 1,9 | — | — | 103 |
| 2014 | Q1 | Q2 | 0,897 | 2 | 2,1 | — | — | 103 |
| 2013 | Q1 | Q3 | 0,956 | 1,9 | 2 | — | — | 103 |
| 2012 | Q1 | Q2 | 0,906 | 2,1 | 2 | — | — | 103 |
| 2011 | Q1 | Q2 | 0,839 | 2 | 1,9 | — | — | 103 |
| 2010 | Q1 | Q2 | 0,865 | 1,9 | 1,9 | — | — | 103 |
| 2009 | — | Q3 | — | 1,7 | 1,8 | — | — | — |
| 2008 | — | Q3 | — | 1,3 | 1,9 | — | — | — |
| 2007 | — | Q3 | — | 1,4 | 1,9 | — | — | — |
| 2006 | — | Q2 | — | 1,9 | — | — | — | — |
| 2005 | — | Q2 | — | 2,1 | — | — | — | — |
| 2004 | — | Q3 | — | 1,5 | — | — | — | — |
| 2003 | — | Q4 | — | 0,9 | — | — | — | — |
| 2002 | — | Q3 | — | 1 | — | — | — | — |
| 2001 | — | Q1 | — | 1,9 | — | — | — | — |
| 2000 | — | Q2 | — | 1,7 | — | — | — | — |
| 1999 | — | Q2 | — | 1,1 | — | — | — | — |
| 1998 | — | Q3 | — | 0,8 | — | — | — | — |
| 1997 | — | Q3 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q4 | Q3 | 141/183 |
| 2025 | MICROBIOLOGY | SCIE | Q4 | Q3 | 127/167 |
| 2025 | PATHOLOGY | SCIE | Q2 | Q3 | 44/89 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 119/183 |
| 2024 | MICROBIOLOGY | SCIE | Q3 | Q3 | 99/163 |
| 2024 | PATHOLOGY | SCIE | Q2 | Q3 | 35/90 |
| 2023 | IMMUNOLOGY | SCIE | Q4 | Q3 | 137/181 |
| 2023 | MICROBIOLOGY | SCIE | Q3 | Q3 | 114/161 |
| 2023 | PATHOLOGY | SCIE | Q3 | Q3 | 47/88 |
| 2022 | IMMUNOLOGY | SCIE | Q4 | Q3 | 122/161 |
| 2022 | MICROBIOLOGY | SCIE | Q3 | Q3 | 91/135 |
| 2022 | PATHOLOGY | SCIE | Q2 | Q3 | 37/76 |
| 2021 | IMMUNOLOGY | SCIE | Q3 | Q3 | 116/162 |
| 2021 | MICROBIOLOGY | SCIE | Q3 | Q3 | 81/137 |
| 2021 | PATHOLOGY | SCIE | Q2 | Q3 | 34/77 |
| 2020 | IMMUNOLOGY | SCIE | Q3 | Q3 | 111/162 |
| 2020 | MICROBIOLOGY | SCIE | Q3 | Q3 | 80/136 |
| 2020 | PATHOLOGY | SCIE | Q2 | Q3 | 35/77 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q3 | 116/159 |
| 2019 | MICROBIOLOGY | SCIE | Q3 | Q3 | 87/136 |
| 2019 | PATHOLOGY | SCIE | Q2 | Q3 | 32/78 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q3 | 121/158 |
| 2018 | MICROBIOLOGY | SCIE | Q3 | Q3 | 91/133 |
| 2018 | PATHOLOGY | SCIE | Q2 | Q3 | 33/76 |
| 2017 | IMMUNOLOGY | SCIE | Q4 | Q3 | 124/155 |
| 2017 | MICROBIOLOGY | SCIE | Q3 | Q3 | 84/126 |
| 2017 | PATHOLOGY | SCIE | Q2 | Q3 | 38/79 |
| 2016 | IMMUNOLOGY | SCIE | Q4 | — | 122/151 |
| 2016 | MICROBIOLOGY | SCIE | Q3 | — | 84/125 |
| 2016 | PATHOLOGY | SCIE | Q3 | — | 43/79 |
| 2015 | IMMUNOLOGY | SCIE | Q4 | — | 120/151 |
| 2015 | MICROBIOLOGY | SCIE | Q3 | — | 84/123 |
| 2015 | PATHOLOGY | SCIE | Q2 | — | 37/79 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 107/148 |
| 2014 | MICROBIOLOGY | SCIE | Q3 | — | 80/119 |
| 2014 | PATHOLOGY | SCIE | Q2 | — | 35/76 |
| 2013 | IMMUNOLOGY | SCIE | Q4 | — | 113/144 |
| 2013 | MICROBIOLOGY | SCIE | Q3 | — | 80/119 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 43/76 |
| 2012 | IMMUNOLOGY | SCIE | Q3 | — | 100/137 |
| 2012 | MICROBIOLOGY | SCIE | Q3 | — | 70/116 |
| 2012 | PATHOLOGY | SCIE | Q2 | — | 35/77 |
| 2011 | IMMUNOLOGY | SCIE | Q3 | — | 104/139 |
| 2011 | MICROBIOLOGY | SCIE | Q3 | — | 70/114 |
| 2011 | PATHOLOGY | SCIE | Q2 | — | 36/79 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 101/134 |
| 2010 | MICROBIOLOGY | SCIE | Q3 | — | 66/107 |
| 2010 | PATHOLOGY | SCIE | Q2 | — | 38/76 |
| 2009 | IMMUNOLOGY | SCIE | Q4 | — | 102/128 |
| 2009 | MICROBIOLOGY | SCIE | Q3 | — | 69/95 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 37/71 |
| 2008 | IMMUNOLOGY | SCIE | Q4 | — | 104/121 |
| 2008 | MICROBIOLOGY | SCIE | Q4 | — | 73/91 |
| 2008 | PATHOLOGY | SCIE | Q3 | — | 49/69 |
| 2007 | IMMUNOLOGY | SCIE | Q4 | — | 98/119 |
| 2007 | MICROBIOLOGY | SCIE | Q3 | — | 67/93 |
| 2007 | PATHOLOGY | SCIE | Q3 | — | 41/66 |
| 2006 | IMMUNOLOGY | SCIE | Q3 | — | 83/117 |
| 2006 | MICROBIOLOGY | SCIE | Q3 | — | 63/89 |
| 2006 | PATHOLOGY | SCIE | Q2 | — | 30/64 |
| 2005 | IMMUNOLOGY | SCIE | Q3 | — | 65/115 |
| 2005 | MICROBIOLOGY | SCIE | Q3 | — | 48/86 |
| 2005 | PATHOLOGY | SCIE | Q2 | — | 23/66 |
| 2004 | IMMUNOLOGY | SCIE | Q3 | — | 81/111 |
| 2004 | MICROBIOLOGY | SCIE | Q3 | — | 55/84 |
| 2004 | PATHOLOGY | SCIE | Q3 | — | 33/65 |
| 2003 | IMMUNOLOGY | SCIE | Q4 | — | 95/114 |
| 2003 | MICROBIOLOGY | SCIE | Q4 | — | 64/84 |
| 2003 | PATHOLOGY | SCIE | Q4 | — | 52/64 |
| 2002 | IMMUNOLOGY | SCIE | Q4 | — | 95/119 |
| 2002 | MICROBIOLOGY | SCIE | Q3 | — | 60/82 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 41/64 |
| 2001 | IMMUNOLOGY | SCIE | Q3 | — | 62/114 |
| 2001 | MICROBIOLOGY | SCIE | Q2 | — | 35/81 |
| 2001 | PATHOLOGY | SCIE | Q1 | — | 16/66 |
| 2000 | IMMUNOLOGY | SCIE | Q3 | — | 65/116 |
| 2000 | MICROBIOLOGY | SCIE | Q2 | — | 35/83 |
| 2000 | PATHOLOGY | SCIE | Q2 | — | 19/67 |
| 1999 | IMMUNOLOGY | SCIE | Q3 | — | 83/115 |
| 1999 | MICROBIOLOGY | SCIE | Q3 | — | 50/79 |
| 1999 | PATHOLOGY | SCIE | Q2 | — | 32/66 |
| 1998 | IMMUNOLOGY | SCIE | Q4 | — | 98/120 |
| 1998 | MICROBIOLOGY | SCIE | Q3 | — | 58/81 |
| 1998 | PATHOLOGY | SCIE | Q3 | — | 41/68 |
| 1997 | IMMUNOLOGY | SCIE | Q3 | — | 81/117 |
| 1997 | MICROBIOLOGY | SCIE | Q3 | — | 46/73 |
| 1997 | PATHOLOGY | SCIE | Q3 | — | 35/66 |